FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness – NPR
NPR |
FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness
NPR A panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness. Spark Therapeutics hide caption. toggle caption. Spark Therapeutics. A panel of experts has … FDA Advisers Endorse Gene Therapy to Treat Form of Blindness Spark’s Gene Therapy to Treat Blindness Gets Closer to Approval FDA Considers Gene Therapy for Rare Eye Disease |
View original article
Author: